Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

ICU artery study pulled before starting

NCT ID NCT03621618

Knowledge-focused Sponsor: Universitair Ziekenhuis Brussel Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study was designed to measure how stiff the arteries are in intensive care patients receiving drugs to support their heart or blood pressure. The goal was to see if a simple monitor reading could help doctors adjust treatment. However, the study was withdrawn before any patients were enrolled, so no results are available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Started

Mar 2019

Finished

Jun 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \- ICU patients, treated/supported with noradrenalin or dobutamine. Exclusion Criteria: * Septic shock * Aortic valve regurgitation and defect of septum * Severe aortic sclerosis, aortic prosthesis * Severe hypertension (MAP \> 130 mmHg) * Cardiac arrhythmia * Tachycardia with a heart rate higher than 150 bpm * Age below 18 or above 75 y * Patient height below 120 cm (48") or above 230 cm (90") * Patient weight less than 30 kg (67 lbs.) or greater than 155 kg (341 lbs.) * Intra-aortic balloon pump

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac failure acute are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

heart failure infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac failure acute Sepsis

Contacts and locations

Locations

  • universitair Ziekenhuis Brussel

    Jette, Vlaams Brabant, 1090, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.